0 CHECKOUT

PRODUCT FILTERS

REGION

79
59
58
53
53

COUNTRY

53
5
5
5
5

PRICE

2
29
55
192

PUBLISHED

49
53
105
192

PRODUCT TYPE

191
1

Prostate Cancer

The second leading cause of new cancer cases in men worldwide with over two million sufferers in the US alone, prostate cancer is typically a disease that affects older men and is thus on the increase as global life expectancies continue to rise. It is also one of the largest sectors of the pharmaceutical oncology industry. Expertly formulated reports in this section will help you to formulate effective market strategies by answering key questions such as who are the main and key niche players, what are the new drugs and therapies (including vaccines and therapeutic antibodies) in the pipeline, and what are the latest areas of pharmaceutical R&D. Manufacturers will find multiple report options to assist them in assessing competition and market opportunities. Show Less Read more

World Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics - Market Opportunity and Forecast, 2014 - 2020

Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining...

Published:  July 2015
Price:  From

Global Prostate Cancer Devices Market 2015-2019

About Prostate Cancer Prostate cancer is one of the most common cancer in men. It occurs in the prostate gland, a small walnut-shaped gland. The primary function of the prostate gland is to produce...

Published:  June 2015
Price:  From

Investigation Report on China's Capecitabine Market, 2010-2019

Capecitabine, developed by F. Hoffmann-La Roche Ltd, entered the markets in the US, Canada and Sweden in 1998 under the trade name of Xeloda and then spread through over 80 countries and regions in...

Published:  June 2015
Price:  From

Therapeutic Class Overview: Newer Oral Anti Androgens – Expanding Role in the Treatment Paradigm of Prostate Cancer

XTANDI (Enzalutamide) – Does it have potential to compete against ARN-509 in earlier setting? Zytiga (Abiraterone Acetate) – Ongoing Combination trials creates potential beyond Patent Expiry In recent...

Published:  February 2014
Price:  From

CAS Estradiol valerate World Consumption Report

This CAS Estradiol valerate World Consumption Report provides data on the net consumption of CAS 979-32-8 - Estradiol valerate Substance(s) in each of the countries listed. The Substance(s) covered...

Published:  February 2016
Price: 

Capecitabine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

CAS 17beta-Estradiol 17-acetate World Consumption Report

This CAS 17beta-Estradiol 17-acetate World Consumption Report provides data on the net consumption of CAS 1743-60-8 - 17beta-Estradiol 17-acetate Substance(s) in each of the countries listed. The Substance(s)...

Published:  February 2016
Price: 

Enzalutamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

Enzalutamide - Comprehensive patent search

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, these In-depth Searches...

Published:  February 2016
Price: 

Enzalutamide (MDV-3100) - Comprehensive patent search

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, these In-depth Searches...

Published:  February 2016
Price: 

CAS Ethynyl estradiol World Consumption Report

This CAS Ethynyl estradiol World Consumption Report provides data on the net consumption of CAS 57-63-6 - Ethynyl estradiol Substance(s) in each of the countries listed. The Substance(s) covered (Ethynyl...

Published:  February 2016
Price: 

CAS Cyclophosphamide World Consumption Report

This CAS Cyclophosphamide World Consumption Report provides data on the net consumption of CAS 50-18-0 - Cyclophosphamide Substance(s) in each of the countries listed. The Substance(s) covered (Cyclophosphamide...

Published:  February 2016
Price: 

CAS Estradiol benzoate World Consumption Report

This CAS Estradiol benzoate World Consumption Report provides data on the net consumption of CAS 50-50-0 - Estradiol benzoate Substance(s) in each of the countries listed. The Substance(s) covered (Estradiol...

Published:  February 2016
Price: 

CAS Estradiol World Consumption Report

This CAS Estradiol World Consumption Report provides data on the net consumption of CAS 50-28-2 - Estradiol Substance(s) in each of the countries listed. The Substance(s) covered (Estradiol ) are classified...

Published:  February 2016
Price: 

Abiraterone - Comprehensive patent search

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, these In-depth Searches...

Published:  February 2016
Price: 

Cabazitaxel - Comprehensive patent search

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, these In-depth Searches...

Published:  February 2016
Price: 

Capecitabine - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-API Insights

Summary Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-API Insights, 2015 report provides Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent)...

Published:  February 2016
Price:  From

Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights

Summary Metastatic Hormone Refractory Prostate Cancer- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Metastatic Hormone Refractory Prostate Cancer. The main objective...

Published:  February 2016
Price:  From

Enzalutamide - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  February 2016
Price: 
Loading Indicator

Our Clients